• Logo
  • SBMUJournals

How much does vaccination reduce the rate of HBV infection in Iranian population? a Bayesian adjustment analysis

Sajad Shojaee, Farid Zayeri, Maryam Nasserinejad, Ali Ghasemzadeh, Saeedeh Sadat Beheshti Shirazi, Mahsa Khodadoostan





The aim of this research was to estimate the changing rate of odds ratio (OR) by varying degrees of hepatitis B virus (HBV) underreporting.


Data registering is usually associated with much errors such as misclassification, under-reporting, missing data due to lack of co-operation, error prone factor, and also in medical studies due to inadequate diagnosis of physician or low accuracy of laboratory tests. In the present study, which discuss about the actual impact of vaccination on HBV prevention, exposure and response were prone to various errors. Furthermore, some people in the community possibly infected to virus while were not reported in the count of patients with HBV infected.


This was a Case control study. Cases include patients with HBV who were referred to the gastroenterology and liver disease research center. Control group include patients without HBV who were performed a fatty liver test at Taleghani hospital laboratory. Bayesian approach and Gibbs sampling algorithm were used to estimate OR.


According to results, misclassification rate was mild in raw data but with an increase in degree of underreporting for 50 and 500 of unreported cases, OR increased about half and more than double, respectively, while sensitivity decreased strikingly.


Our analysis asserted that knowing the degree of underreporting is essential to accurately calculate OR and sensitivity. In addition, despite varying OR in the different samples, overall results were similar according to the pattern of exposure and response association.

Key Words: Vaccination, Hepatitis B virus, Misclassification, Underreporting, Bayesian adjustment


Vaccination, Hepatitis B virus, Misclassification, Underreporting, Bayesian adjustment


Hepatitis B. available from http://www.who.int/mediacentre/factsheets/fs204/en/ 2019. .

Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009;49:S13-S21.

Lusida MI, Juniastuti YY. Current hepatitis B virus infection situation in Indonesia and its genetic diversity. World journal of gastroenterology 2016;22:7264.

Ghosh A, Singh V, Chawla S. Seroprevalence of Hepatitis B Virus Infection among Blood Donors in a Tertiary Care Hospital Western UP. virus 2015;13:16.

Marugán RB, Garzón SG. DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World Journal of Gastroenterology: WJG 2009;15:423.

negative Susceptible H. Interpretation of Hepatitis B Serologic Test Results.

Organization WH. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA;3.

Shelmani HM, Karayiannis P, Ashtari S, Mahmanzar MA, Khanabadi B, Modami N, et al. Demographic changes of hepatitis B virus infection in Iran for the last two decades. Gastroenterology and hepatology from bed to bench 2017;10:S38.

Sayehmiri K, Azami M, Nikpey S, Borji M, Sayehmiri F. Hepatitis B vaccination coverage in health personnel of Iran: a systematic review and meta-analysis study. Iranian Journal of Epidemiology 2015;11:1-10.

Azami M, Borji M, Ghanbari F, Nikpay S, Sayehmiri K. Hepatitis B vaccination coverage of physicians and nurses in Iran: a systematic review and meta-analysis study. Journal of Birjand University of Medical Sciences 2015;22:304-15.

Azami M, Sayehmiri K, Darvishi Z, Sayehmiri F. Hepatitis B vaccination coverage among dentists in Iran: a systematic review and metaanalysis study. Hepat Mon 2015;15:37.

Zamani F, Fallahian F, Hashemi F, Shamsaei Z, Alavian S-M. Immune response to hepatitis B vaccine in health-care workers. Saudi Journal of Kidney Diseases and Transplantation 2011;22:179.

Salehi-Vaziri M, Sadeghi F, Hashiani AA, Fesharaki MG, Alavian SM. Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis. Hepatitis monthly 2016;16.

Agresti A, Kateri M. Categorical data analysis: Springer; 2011.

Goldstein ND, Burstyn I, Newbern EC, Tabb LP, Gutowski J, Welles SL. Bayesian Correction of Misclassification of Pertussis in Vaccine Effectiveness Studies: How Much Does Underreporting Matter? American journal of epidemiology 2016;183:1063-70.

Gustafson P. Measurement error and misclassification in statistics and epidemiology: impacts and Bayesian adjustments: Chapman and Hall/CRC; 2003.

Luta G, Ford MB, Bondy M, Shields PG, Stamey JD. Bayesian sensitivity analysis methods to evaluate bias due to misclassification and missing data using informative priors and external validation data. Cancer epidemiology 2013;37:121-6.

Alizadeh A, Ranjbar M, Ansari S, MirArab A, Alavian S, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health Journal, 12 (5), 528-537, 2006 2006.

Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 2010;138:1747-54. e1.

Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepatitis monthly 2011;11:346.

Coppola N, Corvino AR, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, et al. The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy. BMC infectious diseases 2015;15:149.

Carlo CM. Markov chain monte carlo and gibbs sampling. Lecture notes for EEB 2004;581.

Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepatitis monthly 2008;8.

Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 2009;14:249.

Roberts H, Boktor SW, Waller K, Daar ZS, Boscarino JA, Dubin PH, et al. Underreporting of Hepatitis B and C virus infections—Pennsylvania, 2001–2015. PloS one 2019;14:e0217455.

Brass V, Moradpour D. New insights into hepatitis B and C virus co-infection. Journal of hepatology 2009;51:423-5.

Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Annals of clinical microbiology and antimicrobials 2005;4:13.

Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. Journal of gastroenterology and hepatology 2008;23:512-20.

Kirkey K, MacMaster K, Suryaprasad A, Xu F, Klevens M, Roberts H, et al. Completeness of reporting of chronic hepatitis B and C virus infections—Michigan, 1995–2008. MMWR Morbidity and mortality weekly report 2013;62:99.

DOI: https://doi.org/10.22037/ghfbb.v12i0.1822